Commission Regulation (EEC) No 2061/89
Of 7 July 1989 — CELEX 31989R2061
Description of the goods
1. Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from food lacking in proteins. Composition per 100 g of the preparation: — L-histidine: 4,2 g — L-isoleucine: 4,2 g — L-leucine: 4,2 g — L-lysine: 4,2 g — L-methionine: 4,2 g — L-phenylalanine: 4,2 g — L-threonine: 4,2 g — L-tryptophan: 4,2 g — L-valine: 4,2 g — L-cystine: 2,8 g — L-glycine: 2,8 g — L-cysteïn: 2,8 g — L-tyrosine: 2,8 g — L-taurine: 2,8 g — L-arginine: 2,8 g — L-ornithine: 2,8 g — L-glutamine: 2,8 g — L-alanine: 1,4 g — L-aspartic acid: 1,4 g — L-glutamic acid: 1,4 g — L-citruline: 1,4 g — L-serine: 1,4 g — L-proline: 1,4 g — L-glutathion: 1,4 g — L-carnitine: 1,4 g — Cellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g
Reasons
Classfication is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 91. The products is a food supplement (see also HS Explanatory Notes to CN code 2106)
Description of the goods
2. Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter, in particular, deficiency resulting from the growth of children. Composition per 100 g of the preparation: — glycine: 36,2 g — L-ornithine: 27,2 g — L-tryptophan: 9,1 g — Niacinamide: 2,2 g — Vitamin B6: 0,8 g; — Cellulose, stearic acid, magnesium stearate, silicon dioxide, and food glaze containing protein: ad 100 g
Reasons
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 91. The product is a food supplement (see also HS Explanatory Notes to CN code 2106)
Description of the goods
3. Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from the menstruation of women. Composition per 100 g of the preparation: — Oil of evening primrose: 11,4 g — Vitamin B6: 6,8 g — Magnesium oxide: 5,7 g — Calcium carbonate: 2,9 g — Herbal mixture: 2,4 g — Potassium gluconate: 2,3 g — Folic acid: 0,009 g — Cellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g
Reasons
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 91. The product is a food supplement (see also HS code Explanatory Notes to CN code 2106)
Description of the goods
4. Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition, to ensure a balance of substances contained in hair. Each tablet of approximately 2g contains: — Biotin: 500 μg — L-Cysteine: 150 mg — Choline bitartrate: 125 mg — Inositol: 62,5 mg — Vitamin B12: 12,5 μg — Folic acid: 400 μg — Ascorbic acid: 150 mg — Manganese gluconate: 5 mg — Para aminobenzoic acid: 37,5 mg — Niacinamide: 15 mg — Panothenic acid: 50 mg — Vitamin B6: 37,5 mg — Zinc gluconate: 15 mg — Ferrous gluconate: 10 mg — Iodine: 75 μg — Copper gluconate: 1 mg — Millet extract: 200 mg In a base containing: Beta carotene, aloe vera, amino acids, cellulose, stearic acid and food glaze containing protein
Reasons
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 91. The product is a food supplement (see also HS Explanatory Notes to CN code No 2106)
Description of the goods
5. Preparation in the form of tablets put up in packages for retail sale with instructions on dosage and composition, to counter deficiency in vitamin C. Each tablet weighing 750 mg contains: — Ascorbic acid: 500 g — Rose hip poweder, cellulose, vegetable stearine, botanical oil solids, magnesium stearate, silicon dioxide and food glaze containing protein: 250 mg
Reasons
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 91. The product is a food supplement (see also HS Explanatory Notes to CN code 2106)
Description of the goods
6. Injectable preparation, sterile, pyrogen-free, consisting of purified collagen dispersed in a phosphate physiological saline buffered solution, whether or not containing lidocaine (INN), put up for retail sale
Reasons
Classficiation is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 3004, 3004 90 and 3004 90 91. This product is used in the treatment of atrophy due to disease, trauma or other disorders of the conjunctive tissue